Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) EBT: 2023-2024

Historic EBT for Pyxis Oncology (PYXS) over the last 2 years, with Dec 2024 value amounting to -$79.5 million.

  • Pyxis Oncology's EBT fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$102.6 million, marking a year-over-year change of. This contributed to the annual value of -$79.5 million for FY2024, which is 7.73% down from last year.
  • Pyxis Oncology's EBT amounted to -$79.5 million in FY2024, which was down 7.73% from -$73.8 million recorded in FY2023.
  • Over the past 5 years, Pyxis Oncology's EBT peaked at -$73.8 million during FY2023, and registered a low of -$79.5 million during FY2024.
  • For the 2-year period, Pyxis Oncology's EBT averaged around -$76.6 million, with its median value being -$76.6 million (2023).
  • Data for Pyxis Oncology's EBT shows a maximum YoY declined of 7.73% (in 2024) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's EBT (Yearly) stood at -$73.8 million in 2023, then fell by 7.73% to -$79.5 million in 2024.